Article Versions Notes

Touloupas C, Faron M, Hadoux J, Deschamps F, Roux C, Ronot M, Yevich S, Joskin J, Gelli M, Barbé R, et al. Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience. Cancers. 2021; 13(21):5366. https://doi.org/10.3390/cancers13215366

Touloupas, Caroline, Matthieu Faron, Julien Hadoux, Frédéric Deschamps, Charles Roux, Maxime Ronot, Steven Yevich, Julien Joskin, Maximiliano Gelli, Rémy Barbé, and et al. 2021. "Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience" Cancers 13, no. 21: 5366. https://doi.org/10.3390/cancers13215366

Touloupas, C., Faron, M., Hadoux, J., Deschamps, F., Roux, C., Ronot, M., Yevich, S., Joskin, J., Gelli, M., Barbé, R., Lamartina, L., Tissot, H., Scoazec, J.-Y., Malka, D., Ducreux, M., Baudin, E., de Baère, T., & Tselikas, L. (2021). Long Term Efficacy and Assessment of Tumor Response of Transarterial Chemoembolization in Neuroendocrine Liver Metastases: A 15-Year Monocentric Experience. Cancers, 13(21), 5366. https://doi.org/10.3390/cancers13215366